Finance

Beta
Lists
688166:SHA
BrightGene Bio-Medical Technology Co Ltd
CN¥35.96
+4.66%
(+1.60) 1D
Jun 29, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688166...
Open
CN¥34.52
High
CN¥36.69
Low
CN¥33.50
Mkt. cap
14.97B
Avg. vol.
12.57M
Volume
15.60M
Dividend
0.04%
Quarterly dividend
CN¥0.00
Ex-dividend date
Jun 9, 2026
P/E ratio
298.30
52-wk high
CN¥122.59
52-wk low
CN¥33.50
EPS
CN¥0.12
No. of employees
1K
Open
CN¥34.52
High
CN¥36.69
Low
CN¥33.50
Mkt. cap
14.97B
Avg. vol.
12.57M
Volume
15.60M
Dividend
0.04%
Quarterly dividend
CN¥0.00
Ex-dividend date
Jun 9, 2026
P/E ratio
298.30
52-wk high
CN¥122.59
52-wk low
CN¥33.50
EPS
CN¥0.12
No. of employees
1K
News stories
From sources across the web
About BrightGene Bio-Medical Technology Co Ltd
CEO-
Employees1.2K
FoundedOct 26, 2001
Headquarters-
SectorPharmaceutical industry
Websitebright-gene.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
288.48M
336.81M
349.39M
324.93M
Cost of goods sold
138.88M
146.49M
190.48M
140.46M
Cost of revenue
138.88M
146.49M
190.48M
140.46M
Research and development expenses
76.65M
78.14M
88.52M
120.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.45M
64.94M
57.21M
44.04M
Operating expense
127.81M
143.79M
168.94M
172.93M
Total operating expenses
266.68M
290.29M
359.43M
313.39M
Operating income
21.79M
46.52M
-10.03M
11.54M
Other non operating income
-4.11M
7.34M
-8.39M
-2.77M
EBT including unusual items
6.84M
27.44M
-8.51M
-3.48M
EBT excluding unusual items
11.91M
33.06M
-29.33M
-9.49M
Income tax expense
528.81K
-2.29M
-14.07M
-12.98M
Effective tax rate
7.73%
-8.36%
165.46%
373.27%
Other operating expenses
303.68K
-547.06K
395.69K
76.94K
Net income
4.21M
33.15M
4.19M
9.29M
Net profit margin
1.46%
9.84%
1.20%
2.86%
Earnings per share
-
-
-
-
Interest and investment income
1.82M
4.99M
-
311.49K
Interest expense
-14.05M
-19.34M
-17.00M
-18.58M
Net interest expenses
-12.23M
-14.35M
-17.00M
-18.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
57.22M
70.48M
25.86M
47.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of 688166
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer